连续两次CT扫描的COVID-19患者肝脾比值、肺部CT评分与临床及实验室检查结果的相关性
回顾性纳入2020年3月1日至4月26日间RT-PCR阳性且完成两次平扫胸部CT的COVID-19患者,按肺部CT评分分为进展组20例与非进展组7例,比较肝脾比值(L/S)与临床实验室指标。进展组随访时L/S均值1.02±0.23,低于非进展组的1.25±0.29(p=0.009);L/S与AST、ALT呈负相关。
要点
- 随访CT上进展组肝脾比值低于非进展组,提示L/S下降可能与肺部CT评分升高相关。
- 入院时两组L/S无显著差异,进展组1.13±0.3 vs 非进展组1.21±0.29(p=0.547)。
- 入院时WBC、中性粒细胞、淋巴细胞、单核细胞及血小板计数在两组间有显著差异。
关键影像表现/征象
- 进展组入院时肝脾比值均值1.13±0.3,非进展组1.21±0.29,两组无显著差异(p=0.547)。
- 随访时进展组肝脾比值均值1.02±0.23,非进展组1.25±0.29,两组差异显著(p=0.009)。
- 肝脾比值与AST呈负相关(r=-0.46,p=0.016),与ALT呈负相关(r=-0.534,p=0.004)。
诊断标准与关键数值
- 按肺部CT评分将患者分为非进展组与进展组。
- 进展组随访肝脾比值均值1.02±0.23 vs 非进展组1.25±0.29(p=0.009)。
- 入院时肝脾比值进展组1.13±0.3 vs 非进展组1.21±0.29(p=0.547),无显著差异。
临床应用与阅片要点
- 作者结论提示随访CT上肝脾比值下降可伴随肺部CT评分升高。
- 作者结论提示入院时WBC、中性粒细胞、淋巴细胞、单核细胞和血小板计数可能预测COVID-19进展。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Given the lack of information about abdominal imaging findings and correlation with clinical features of COVID-19, we aimed to evaluate the changes in hepatic attenuation during the course of disease. Our aim was to correlate the liver-to-spleen ratio (L/S), clinical, laboratory findings, and lung CT scores of patients with COVID-19 who had two consecutive chest CTs.
METHODS: A retrospective search was performed between March 1, 2020 and April 26, 2020 to identify patients who had positive RT-PCR tests and two unenhanced chest CTs. Scans that were obtained at hospital admission and follow-up were reviewed to assess L/S and lung CT scores. Patients were divided into two groups based on lung CT scores (non-progressive vs progressive). Patient demographics, laboratory findings, length of hospital stay, and survival were noted from electronic medical records.
RESULTS: Twenty patients in the progressive group and 7 patients in the non-progressive group were identified. The mean L/S of the progressive group (1.13 ± 0.3) was lower than that of the non-progressive group (1.21 ± 0.29) at hospital admission but there was no significant difference between the two groups (p = 0.547). L/S at follow-up was significantly different between the groups as the mean L/S values of the progressive and non-progressive groups were 1.02 ± 0.23 and 1.25 ± 0.29, respectively (p = 0.009). L/S was negatively correlated with AST and ALT (r = - 0.46, p = 0.016 and r = - 0.534, p = 0.004, respectively). There were significant differences between the two groups in terms of WBC, neutrophil, lymphocyte, monocyte, and platelet counts that were obtained at hospital admission. Length of hospital stay was significantly longer in patients in the progressive group (p = 0.035).
CONCLUSIONS: Decrease in L/S may be observed in patients with elevated lung CT scores at follow-up. WBC, neutrophil, lymphocyte, monocyte, and platelet counts at hospital admission may predict the progression of COVID-19.
引用
- Guler E, Unal NG, Cinkooglu A, et al. Correlation of liver-to-spleen ratio, lung CT scores, clinical, and laboratory findings of COVID-19 patients with two consecutive CT scans. Abdom Radiol (NY). 2020. PMID: 33051758. doi:10.1007/s00261-020-02805-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。